Wednesday, August 1, 2007

NYX reports on the late night! ... zzzzz...zzz ... NYSE EURONEXT (NYX:NYSE)

(NYX: NYSE)
Mean Estimate:
$0.64
High Estimate:
$0.70

Low Estimate:
$0.57

.
.

The consensus of the 13 analysts covering NYX for 2nd quarter 2007 is a per share value of $.64.


NEW YORK – Aug. 2, 2007 – NYSE Euronext (NYSE Euronext: NYX) today reported net income of $161 million, or $0.62 per diluted share, for the three months ended June 30, 2007, a 164% increase as compared to net income of $61 million, or $0.39 per diluted share, for the three months ended June 30, 2006.


Extended Hours:
Last 77.99
Change +1.01 (+1.31%)


....Not the most exciting news ever, looks like a miss, right? (62<64)

NYX is the GLOBAL exchange of choice ....right? ...

BOTD LOVES NYX!

.... stay LONG NYX with our common shares...BUY ON THE DIP!

....as for the DIPfolio NYX OPTIONS plays, let's SELL and take profits on any spike!

7 comments:

Anonymous said...

PARIS, Aug 2 (Reuters) - NYSE Euronext NYX.PA (NYX) reported a 164 percent jump in its second-quarter profit on Thursday, as the transatlantic stock exchange operator posted its first combined results following the merger of the NYSE Group and Euronext.

Net income rose to $161 million, or 62 cents per share for the three-months period ended June 30, up from $61 million, or 39 cents per share in the corresponding period a year earlier.

Anonymous said...

NYX beats by .2cents!

Reports Q2 (Jun) earnings of $0.65 per share, excluding non-recurring items, $0.02 better than the Reuters Estimates consensus of $0.63; revenues rose 17.9% year/year to $975 mln vs the $852.5 mln consensus.

Anonymous said...

NEVER FORGET THE POWER OF "voodoo math"

Anonymous said...

S&P MAINTAINS BUY RECOMMENDATION ON SHARES OF NYSE EURONEXT
S&P Marketscope -


Related Quotes
Symbol Last Chg
NYX Trade 76.98 0.00
Quotes delayed at least 15 minutes

SNPMarketScopeResearchNotes2007-08-02 09:17:13.000NYXNYSE EURONEXTJWilleyS&P MAINTAINS BUY RECOMMENDATION ON SHARES OF NYSE EURONEXTQ2 EPS of $0.62 vs. $0.39 is a penny below our estimate, but includes $0.03 of merger and non-recurring expenses. European cash equities and derivatives set revenue records during the quarter, and trading volumes remained strong across the entire company in July as market volatility accelerated. Our '07 EPS estimate is unchanged at $2.45, and '08's remains $3.48. We are reducing our 12-month target price by $14 to $90, 26X our '08 estimate, reflecting lower peer multiples. We continue to believe NYX's broad product and geographic exposure position it well for earnings growth.|US;NYX|107272|4362067

Anonymous said...

WTF

Anonymous said...

just keep adding to your position...see you next year!

Anonymous said...

SOLD some POT today, thanks BOTD!

83.81 +4.14 (+5.20%)